Plasma Glial Fibrillary Acid Protein and Phosphorated Tau 181 Association with Presynaptic Density-Dependent Tau Pathology at 18 F-SynVesT-1 Brain PET Imaging.
IF 12.1
1区 医学
Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Junhao Wu, Binyin Li, Jie Wang, Qi Huang, Xing Chen, Zhiwen You, Kun He, Qihao Guo, Songye Li, Yiyun Henry Huang, Tengfei Guo, Wenlin Dai, Weiwei Xiang, Weihuang Chen, Dake Yang, Jun Zhao, Yihui Guan, Fang Xie
求助PDF
{"title":"Plasma Glial Fibrillary Acid Protein and Phosphorated Tau 181 Association with Presynaptic Density-Dependent Tau Pathology at <sup>18</sup>F-SynVesT-1 Brain PET Imaging.","authors":"Junhao Wu, Binyin Li, Jie Wang, Qi Huang, Xing Chen, Zhiwen You, Kun He, Qihao Guo, Songye Li, Yiyun Henry Huang, Tengfei Guo, Wenlin Dai, Weiwei Xiang, Weihuang Chen, Dake Yang, Jun Zhao, Yihui Guan, Fang Xie","doi":"10.1148/radiol.233019","DOIUrl":null,"url":null,"abstract":"<p><p>Background Synaptic loss is an important factor in Alzheimer disease (AD); however, blood assays that conveniently and rapidly reflect changes in synaptic density are lacking. Purpose To correlate multiple potential synaptic blood markers with synaptic density measured using <sup>18</sup>F-SynVesT-1, a fluorine 18 (<sup>18</sup>F)-labeled radiotracer, brain PET and to explore the independent associations between these markers and synaptic density. Materials and Methods This prospective study included 50 cognitively unimpaired (mean age, 65.0 years ± 8.3 [SD]; 37 female) participants and 70 participants with cognitive impairment (mean age, 69.5 years ± 7.9; 43 female) from the Memory Clinic of Shanghai Jiao Tong University Affiliated Ruijin Hospital and communities in Shanghai. Amyloid-β (Aβ) and tau were assessed using <sup>18</sup>F-florbetapir and <sup>18</sup>F-MK6240 PET/CT. Synaptic density was evaluated with <sup>18</sup>F-SynVesT-1 PET/MRI. Pearson correlation analysis was used to investigate relationships of plasma (Aβ42/40 ratio, phosphorylated tau 181 [p-tau-181], glial fibrillary acid protein [GFAP], neurofilament light) and serum (C-reactive protein, tumor necrosis factor-α, α-synuclein, neurogranin, active plasminogen activator inhibitor-1, tissue plasminogen activator) biomarkers with synaptic density. Linear regression models and mediation analysis were used to explore effects of other AD-related pathologies on these relationships. Results Correlations were observed between increased p-tau-181 and GFAP and decreased synaptic density in global cortex (<i>r</i><sub>p-tau-181</sub> = -0.352, <i>r</i><sub>GFAP</sub> = -0.386; both <i>P</i> < .001) and hippocampus (<i>r</i><sub>p-tau-181</sub> = -0.361, <i>r</i><sub>GFAP</sub> = -0.369; both <i>P</i> < .001) at <sup>18</sup>F-SynVesT-1 PET/MRI. The relationships between p-tau-181 and GFAP with <sup>18</sup>F-SynVesT-1 PET/MRI persisted after controlling for plasma Aβ42/40 ratio, Aβ PET, or cortical thickness (<i>P</i> value range, <.001-.01). This association disappeared after controlling for tau PET (<i>P</i> value range, .08-.83). Conclusion Plasma p-tau-181 and GFAP are closely associated with synaptic density measured using <sup>18</sup>F-SynVesT-1 PET/MRI, with the relationship primarily influenced by tau accumulation rather than Aβ deposition or cortical thickness. © RSNA, 2024 <i>Supplemental material is available for this article.</i> See also the editorial by Giannakopoulos in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 2","pages":"e233019"},"PeriodicalIF":12.1000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1148/radiol.233019","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
Background Synaptic loss is an important factor in Alzheimer disease (AD); however, blood assays that conveniently and rapidly reflect changes in synaptic density are lacking. Purpose To correlate multiple potential synaptic blood markers with synaptic density measured using 18 F-SynVesT-1, a fluorine 18 (18 F)-labeled radiotracer, brain PET and to explore the independent associations between these markers and synaptic density. Materials and Methods This prospective study included 50 cognitively unimpaired (mean age, 65.0 years ± 8.3 [SD]; 37 female) participants and 70 participants with cognitive impairment (mean age, 69.5 years ± 7.9; 43 female) from the Memory Clinic of Shanghai Jiao Tong University Affiliated Ruijin Hospital and communities in Shanghai. Amyloid-β (Aβ) and tau were assessed using 18 F-florbetapir and 18 F-MK6240 PET/CT. Synaptic density was evaluated with 18 F-SynVesT-1 PET/MRI. Pearson correlation analysis was used to investigate relationships of plasma (Aβ42/40 ratio, phosphorylated tau 181 [p-tau-181], glial fibrillary acid protein [GFAP], neurofilament light) and serum (C-reactive protein, tumor necrosis factor-α, α-synuclein, neurogranin, active plasminogen activator inhibitor-1, tissue plasminogen activator) biomarkers with synaptic density. Linear regression models and mediation analysis were used to explore effects of other AD-related pathologies on these relationships. Results Correlations were observed between increased p-tau-181 and GFAP and decreased synaptic density in global cortex (r p-tau-181 = -0.352, r GFAP = -0.386; both P < .001) and hippocampus (r p-tau-181 = -0.361, r GFAP = -0.369; both P < .001) at 18 F-SynVesT-1 PET/MRI. The relationships between p-tau-181 and GFAP with 18 F-SynVesT-1 PET/MRI persisted after controlling for plasma Aβ42/40 ratio, Aβ PET, or cortical thickness (P value range, <.001-.01). This association disappeared after controlling for tau PET (P value range, .08-.83). Conclusion Plasma p-tau-181 and GFAP are closely associated with synaptic density measured using 18 F-SynVesT-1 PET/MRI, with the relationship primarily influenced by tau accumulation rather than Aβ deposition or cortical thickness. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Giannakopoulos in this issue.
血浆胶质纤维酸蛋白和磷酸化 Tau 181 与 18F-SynVesT-1 脑 PET 成像中突触前密度依赖性 Tau 病理学的关系
背景 突触损失是阿尔茨海默病(AD)的一个重要因素;然而,目前还缺乏能方便、快速反映突触密度变化的血液检测方法。目的 将多种潜在的突触血液标记物与使用氟18 (18F)标记的放射性示踪剂18F-SynVesT-1和脑PET测量的突触密度相关联,并探讨这些标记物与突触密度之间的独立关联。材料与方法 本前瞻性研究纳入了上海交通大学附属瑞金医院记忆门诊和上海各社区的 50 名认知功能未受损者(平均年龄 65.0 岁 ± 8.3 [SD];37 名女性)和 70 名认知功能受损者(平均年龄 69.5 岁 ± 7.9;43 名女性)。淀粉样蛋白-β(Aβ)和tau采用18F-氟贝他匹和18F-MK6240 PET/CT进行评估。用 18F-SynVesT-1 PET/MRI 评估突触密度。采用皮尔逊相关分析研究血浆(Aβ42/40比值、磷酸化tau 181 [p-tau-181]、胶质纤维酸蛋白[GFAP]、神经丝光)和血清(C-反应蛋白、肿瘤坏死因子-α、α-突触核蛋白、神经粒蛋白、活性纤溶酶原激活物抑制剂-1、组织纤溶酶原激活物)生物标志物与突触密度的关系。线性回归模型和中介分析被用来探讨其他与AD相关的病症对这些关系的影响。结果 在18F-SynVesT-1 PET/MRI上观察到p-tau-181和GFAP的增加与全球皮层(rp-tau-181 = -0.352,rGFAP = -0.386;均P < .001)和海马(rp-tau-181 = -0.361,rGFAP = -0.369;均P < .001)突触密度的降低之间存在相关性。在控制血浆 Aβ42/40 比值、Aβ PET 或皮质厚度后,p-tau-181 和 GFAP 与 18F-SynVesT-1 PET/MRI 之间的关系仍然存在(P 值范围,P 值范围,.08-.83)。结论 血浆 p-tau-181 和 GFAP 与使用 18F-SynVesT-1 PET/MRI 测量的突触密度密切相关,这种关系主要受 tau 累积而非 Aβ 沉积或皮质厚度的影响。RSNA, 2024 这篇文章有补充材料。另请参阅本期 Giannakopoulos 的社论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。